The project, known by the acronym "REDDSTAR" (Repair of Diabetic Damage by Stromal Cell Administration), is being coordinated by Dr Timothy O’Brien, Dean of Medicine and Director of
The allowed claims in Canada are nearly identical to those already issued in the US (US Patent Number 8,236,935) where Sunshine Biopharma is the exclusive licensee. Sunshine Biopharma
Upon closing of the transaction, MabVax and Telik will be combined into a publicly traded company focused on the development of proprietary immunotherapy-based products to diagnose and treat
The 600-plus-page treatise was sent to Health Canada on 5 May 2014. The conditions that must be met before the issuance of a licence are understandably extensive due
The new therapy is indicated for the adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older. Perampanel
Patent applications covering similar claims have issued in Canada and are under review in the US. Preliminary human and animal studies indicate that AAT may considerably reduce the
Ohr Pharmaceutical CEO Dr Irach B. Taraporewala noted that the company is excited to be working with such a prestigious group of retina specialists in this important early
The two parties will jointly develop and produce Fondaparinux, an anti-thrombotic agent and Travoprost and Bimatoprost, two prostaglandin derivative drugs for treating glaucoma. Capitalizing on the strengths and
Dr Janet Sweeney PhD and Corrie Yelland founders of the Phoenix Tears Foundation have been helping cancer patients with Cannabis based medicines while documenting their research since 2006.
The amended agreements provide ProMetic back with the effective control of NantPro and a greater portion of the future value and revenues associated with the development and sales
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.